{"mainPropery":{"diseaseId":10781,"diseaseName":"Goldmann-Favre syndrome","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/10781/goldmann-favre-syndrome","synonyms":["Enhanced S-cone syndrome","Retinoschisis with early hemeralopia","Favre hyaloideoretinal degeneration"],"synonyms-with-source":[{"name":"Enhanced S-cone syndrome","source":"Orphanet"},{"name":"Retinoschisis with early hemeralopia"},{"name":"Favre hyaloideoretinal degeneration"}],"identifiers":[{"identifierType":"OMIM","identifierId":"268100"},{"identifierType":"ORPHANET","identifierId":"53540"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":9,"diseaseTypeName":"Eye diseases","source":"Orphanet"}],"organizations":[{"resourceID":110,"resourceName":"National Alliance for Eye and Vision Research ","abbreviation":"NAEVR","address1":"1801 Rockville Pike, Suite 400","address2":"","address3":"","address4":"","address5":"","city":"Rockville","state":"MD","zip":"20852","country":"United States","phone":"+1-240-221-2905","tty":"","tollFree":"","fax":"","email":"jamesj@eyeresearch.org","url":"https://www.eyeresearch.org/","freeText":""},{"resourceID":478,"resourceName":"Vision of Children Foundation ","abbreviation":"VOC","address1":"12555 High Bluff Drive, Suite 330","address2":"","address3":"","address4":"","address5":"","city":"San Diego","state":"CA","zip":"92130 ","country":"United States","phone":"+1-858-314-7916","tty":"","tollFree":"","fax":"","email":"info@visionofchildren.org","url":"https://www.visionofchildren.org/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/268100' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed?term=%28Goldmann%5BAll%20Fields%5D%20AND%20favre%5BAll%20Fields%5D%20AND%20%28%22syndrome%22%5BMeSH%20Terms%5D%20OR%20%22syndrome%22%5BAll%20Fields%5D%29%29%20OR%20%28Enhanced%5BAll%20Fields%5D%20AND%20S-cone%5BAll%20Fields%5D%20AND%20%28%22syndrome%22%5BMeSH%20Terms%5D%20OR%20%22syndrome%22%5BAll%20Fields%5D%29%29&cmd=DetailsSearch' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Goldmann-Favre syndrome. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":463,"resourceId":1242,"resourceName":"Goldmann-Favre syndrome","descriptionText":"Sharon D, Sandberg M, Caruso R, Berson EL, Dryja TP. <a href='http://www.hadassah-med.com/NR/rdonlyres/1C83C31A-C737-4510-B01C-3E1D25D7B2D9/11199/SharonArchives2003.pdf ' target='_blank'>Shared Mutations in NR2E3 in Enhanced S-cone Syndrome, Goldmann-Favre syndrome, and many cases of clumped pigmentary retinal degeneration</a>. <em>Arch Ophthalmol</em>. 2003;121:1316-1323.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Selected Full-Text Journal Articles"},{"id":465,"resourceId":1242,"resourceName":"Goldmann-Favre syndrome","descriptionText":"Pachydaki SI, Klaver CC, Barbazetto IA, Roy MS, Gouras P, Allikmets R, Yannuzzi LA. <a href='http://archopht.ama-assn.org/cgi/content/full/127/1/71 ' target='_blank'>Phenotypic features of patients with <em>NR2E3 </em>mutations</a>. <em>Arch Ophthalmol</em>. 2009 Jan;127(1):71-5.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Selected Full-Text Journal Articles"},{"id":466,"resourceId":1242,"resourceName":"Goldmann-Favre syndrome","descriptionText":"Audo I, Michaelides M, Robson AG, Hawlina M, Vaclavik V, Sandbach JM, Neveu MM, Hogg CR, Hunt DM, Moore AT, Bird AC, Webster AR, Holder GE. <a href='http://www.iovs.org/content/49/5/2082.long ' target='_blank'>Phenotypic variation in enhanced S-cone syndrome</a>. <em>Invest Ophthalmol Vis Sci.</em> 2008 May;49(5):2082-93.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Selected Full-Text Journal Articles"},{"id":467,"resourceId":1242,"resourceName":"Goldmann-Favre syndrome","descriptionText":"Iannaccone A, Fung KH, Eyestone ME, Stone EM. <a href='http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2677970/?tool=pubmed ' target='_blank'>Treatment of adult-onset acute macular retinoschisis in enhanced s-cone syndrome with oral acetazolamide.</a> <em>Am J Ophthalmol</em>. 2009 Feb;147(2):307-312.e2. Epub 2008 Oct 4.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Selected Full-Text Journal Articles"},{"id":468,"resourceId":1242,"resourceName":"Goldmann-Favre syndrome","descriptionText":"Khan AO, Aldahmesh M, Meyer B. <a href='http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1857689/?tool=pubmed ' target='_blank'>The enhanced S-cone syndrome in children</a>. <em>Br J Ophthalmol</em>. 2007 Mar;91(3):394-6.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Selected Full-Text Journal Articles"},{"id":469,"resourceId":1242,"resourceName":"Goldmann-Favre syndrome","descriptionText":"Jacobson SG, Sumaroka A, Aleman TS, Cideciyan AV, Schwartz SB, Roman AJ, McInnes RR, Sheffield VC, Stone EM, Swaroop A, Wright AF. <a href='http://hmg.oxfordjournals.org/content/13/17/1893.long ' target='_blank'>Nuclear receptor NR2E3 gene mutations distort human retinal laminar architecture and cause an unusual degeneration</a>. <em>Hum Mol Genet</em>. 2004 Sep 1;13(17):1893-902. Epub 2004 Jun 30.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Selected Full-Text Journal Articles"},{"id":470,"resourceId":1243,"resourceName":"Retina general info","descriptionText":"The <a href='http://faculty.washington.edu/chudler/retina.html ' target='_blank'>University of Washington's</a> Neuroscience for Kids Web site has a resource page on the Retina which explains how our rods and cones work. Click on the University of Washington to view the page.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=53540' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:268100' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":4496,"questionText":"What is Goldmann-Favre syndrome?","answerText":"<strong>Goldmann-Favre syndrome</strong>, also known as the severe form of enhanced S-cone syndrome, is a inherited eye disease that affects the&nbsp;light-sensitive part of the eye (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002291.htm\" target=\"_blank\">retina</a>). Within the retina are&nbsp;\"red,\" \"blue,\" and \"green\" cones which allow us to&nbsp;see colors properly; and&nbsp;rods which allows us to see in dim light.&nbsp;People with Goldmann-Favre syndrome are born with an overabundance of blue cones, a reduced number of red and green cones, and few, if any, functional rods.[3464] As a result they experience an increased sensitivity to blue light, varying degrees of red and green&nbsp;cone vision, night blindness occurring from early life, vision loss, and retinal degeneration.[3461] Goldmann-Favre syndrome can be caused by mutations in the <em><a href=\"http://ghr.nlm.nih.gov/gene/NR2E3\" target=\"_blank\">NR2E3</a> </em><a href=\"http://ghr.nlm.nih.gov/handbook/basics/gene\" target=\"_blank\">gene </a>and is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> fashion.[3461]Treatment may include <a href=\"http://www.njretina.com/provided-services/treatments-for-retinal-disease/laser-photocoagulation/\" target=\"_blank\">laser photocoagulation</a> and medication, such as <a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a682756.html\" target=\"_blank\">acetazolamide</a>, <a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a697049.html\" target=\"_blank\">dorzolamide</a> and&nbsp;<span><a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a601207.html\" target=\"_blank\">cyclosporin A</a>.[11540][11541]&nbsp;</span>","dateModified":"2016-05-19T00:00:00"},"basicQuestions":[{"questionId":4497,"questionText":"How is Goldmann-Favre syndrome diagnosed?","answerText":"Goldmann-Favre syndrome may be suspected following <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003881.htm\" target=\"_blank\">ophthalmoscopy</a>&nbsp;examination. Ophthalmoscopy, also known as funduscopy,&nbsp;allows the doctor to&nbsp;look at the&nbsp;back part of the eye (fundus), which includes the <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002291.htm\" target=\"_blank\">retina</a>, optic disc, <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002318.htm\" target=\"_blank\">choroid</a>, and blood vessels. The architecture of the retina in people with Goldmann-Favre syndrome differs remarkably from normal at all disease stages.[3459] Examples of Goldmann-Favre syndrome retinal abnormalities that can be demonstrated by opthalmoscopy include clumps of pigment and atrophic lesions.[3459] <br />\r\n<br />\r\nOther tests that may be used in diagnosing Goldmann-Favre syndrome&nbsp;include <a href=\"http://www.texasheart.org/HIC/Topics/Diag/diag_oct.cfm\" target=\"_blank\">optical coherence tomography</a>,&nbsp;<a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/003388.htm\" target=\"_blank\">electroretinograms</a>, and <a href=\"https://ghr.nlm.nih.gov/primer/testing/genetictesting\" target=\"_blank\">genetic tests</a>. Optical coherence tomography produces&nbsp;specialized photos that show the layers of the retina in cross section. In people with Goldmann-Favre syndrome, optical coherence tomography shows increased retinal thickening.[3459] Electroretinograms measure the activity of the cells in the&nbsp;retina.&nbsp;In Goldmann-Favre syndrome, electroretinograms may demonstrate no or diminished activity in these cells.[3460][11543] Genetic testing to search for disease causing <a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>  in the <em>NR2E3 </em>gene&nbsp;may be used to&nbsp;confirm a suspected diagnosis.[3460]&nbsp;","dateModified":"2011-05-16T15:23:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":3459,"authors":"Jacobson SG, Sumaroka A, Aleman TS, Cideciyan AV, Schwartz SB, Roman AJ, McInnes RR, Sheffield VC, Stone EM, Swaroop A, Wright AF","articleTitle":"Nuclear receptor NR2E3 gene mutations distort human retinal laminar architecture and cause an unusual degeneration","bookWebsiteJournalTitle":"Hum Mol Genet","date":"2004 Sep 1","volume":"","pages":"","url":"http://hmg.oxfordjournals.org/content/13/17/1893.long","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":3460,"authors":"","articleTitle":"Enhanced S-cone syndrome","bookWebsiteJournalTitle":"Online Mendelian Inheritance in Man","date":"2016","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/omim/268100","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11543,"authors":"Sustar M, Perovšek D, Cima I, Stirn-Kranjc B, Hawlina M & Brecelj J","articleTitle":"Electroretinography and optical coherence tomography reveal abnormal post-photoreceptoral activity and altered retinal lamination in patients with enhanced S-cone syndrome","bookWebsiteJournalTitle":"Doc Ophthalmol","date":"June, 2015","volume":"130(3)","pages":"165-77","url":"https://www.ncbi.nlm.nih.gov/pubmed/?term=25663266","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":4498,"questionText":"How might Goldmann Favre syndrome be treated?","answerText":"While treatment options for&nbsp;complications such as,&nbsp;<a href=\"http://dro.hs.columbia.edu/retinoschisis.htm\" target=\"_blank\">retinoschisis</a> and&nbsp;<a href=\"http://www.kellogg.umich.edu/patientcare/conditions/cystoid.macular.edema.html\" target=\"_blank\">cystoid macular edema</a>&nbsp;may be recommended, currently there is not a cure or specific&nbsp;targeted treatment for Goldmann Favre syndrome.[3468][3475]<br />\r\n<br />\r\n<a href=\"http://www.njretina.com/provided-services/treatments-for-retinal-disease/laser-photocoagulation/\" target=\"_blank\">Laser photocoagulation</a>&nbsp;may benefit macular retinoschisis maybe because it results in the debridement of diseased retinal pigment epithelial (RPE) cells and replacement by new cells decreasing the fluid within the macular cysts that could form in the disease.[11541] <br />\r\n<br />\r\nSome improvement of <a href=\"http://www.aoa.org/patients-and-public/eye-and-vision-problems/glossary-of-eye-and-vision-conditions/visual-acuity?sso=y\" target=\"_blank\">visual acuity</a> has been reported after treatments with <a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a601207.html\" target=\"_blank\">cyclosporin A</a> and <a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a682079.html\" target=\"_blank\">bromocriptine</a>.[11542]&nbsp;<a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a682756.html\" target=\"_blank\">Acetazolamide</a>, 125 mg twice daily and topical 2%&nbsp;<a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a697049.html\" target=\"_blank\">dorzolamide</a>&nbsp;have also worked for some patients with macular edema.[11540][11541]&nbsp;","dateModified":"2016-05-19T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":3475,"authors":"Iannaccone A, Fung KH, Eyestone ME, Stone EM","articleTitle":"Treatment of adult-onset acute macular retinoschisis in enhanced s-cone syndrome with oral acetazolamide","bookWebsiteJournalTitle":"Am J Ophthalmol","date":"2009 Feb;147(2):307-312.e2.","url":"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2677970/?tool=pubmed","dateAccessed":"2011-05-16T00:00:00"},{"referenceId":11540,"authors":"Bušic M, Bjeloš M, Bosnar D, Ramic S & Bušic I","articleTitle":"Cystoid macular lesions are resistant to topical dorzolamide treatment in enhanced S-cone syndrome child","bookWebsiteJournalTitle":"Doc Ophthalmol","date":"February, 2016","volume":"132(1)","pages":"67-73","url":"https://www.ncbi.nlm.nih.gov/pubmed/?term=26803827","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11541,"authors":"Salvatore S, Fishman GA & Genead MA","articleTitle":"Treatment of cystic macular lesions in hereditary retinal dystrophies","bookWebsiteJournalTitle":"Surv Ophthalmol","date":"November-December, 2013","volume":"58(6)","pages":"560-84","url":"https://www.ncbi.nlm.nih.gov/pubmed/?term=24160730","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11542,"authors":"","articleTitle":"Goldmann-Favre syndrome","bookWebsiteJournalTitle":"Orphanet","date":"2009","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&data_id=10723","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":4499,"questionText":"What is the typical prognosis for people with Goldmann-Favre syndrome?","answerText":"It is difficult to predict how Goldmann-Favre syndrome may affect a person over time, but tipically, the disease is progressive.&nbsp;Symptoms and symptom severity&nbsp;can vary considerably from person to person.&nbsp;Some people with Goldmann-Favre syndrome experience vision loss and retinal involvement&nbsp;from childhood, while others maintain retinal function into old age.[3468][3467]<br />\r\n<br />\r\nIn general, in childhood Goldmann-Favre syndrome may cause <a href=\"http://www.aapos.org/terms/conditions/9\" target=\"_blank\">accommodative esotropia</a> (eye-crossing) and poor night vision.[3465] <a href=\"http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0002015/\" target=\"_blank\">Farsightedness</a>&nbsp;and night blindness appear to be common features in adults. Other variable signs and symptoms&nbsp;in adults include&nbsp;reduced&nbsp;vision in&nbsp;very bright&nbsp;light,[3466]&nbsp;variable degrees of&nbsp;central vision loss,[3468]&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001015.htm\" target=\"_blank\">astigmatism</a>,&nbsp;&nbsp;<a href=\"http://dro.hs.columbia.edu/retinoschisis.htm\" target=\"_blank\">retinoschisis</a>, and&nbsp;<a href=\"http://www.kellogg.umich.edu/patientcare/conditions/cystoid.macular.edema.html\" target=\"_blank\">cystoid macular edema</a>.[3468]&nbsp;One review found&nbsp;vision (visual acuity) to range from&nbsp;normal to severely reduced&nbsp;among people with retinas affected by&nbsp;<em>NR2E3 </em>mutations. The presence of&nbsp;<a href=\"http://dro.hs.columbia.edu/retinoschisis.htm\" target=\"_blank\">retinoschisis</a>, may be associated with&nbsp;poorer vision.[3468] Some studies have shown improvement of the vision with treatment.[11540]<br />\r\n<br />\r\nWhile <em>NR2E3 </em>mutations are not identified in all people with Goldmann-Favre syndrome, many cases are caused by mutations in this gene. Symptom and symptom severity is likely influenced by&nbsp;which <em>NR2E3&nbsp;</em>mutations are present, as well as&nbsp;other poorly understood genetic and environmental&nbsp;factors.&nbsp;","dateModified":"2016-05-19T00:00:00","resourceClassificationName":"Prognosis","references":[{"referenceId":3465,"authors":"Khan AO, Aldahmesh M & Meyer B","articleTitle":"The enhanced S-cone syndrome in children","bookWebsiteJournalTitle":"Br J Ophthalmol","date":"March, 2007","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1857689/?tool=pubmed","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":3466,"authors":"Pachydaki SI, Klaver CC, Barbazetto IA, Roy MS, Gouras P, Allikmets R, Yannuzzi LA","articleTitle":"Phenotypic Features of Patients With NR2E3 Mutations","bookWebsiteJournalTitle":"Arch Ophthalmol","date":"2009 Jan;127(1):71-5","volume":"","pages":"","url":"http://archopht.ama-assn.org/cgi/content/full/127/1/71","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":3467,"authors":"Sato T, Kuniyoshi K, Nakao A, Shimomura Y, Tomemori R","articleTitle":"Long-term observation of two cases of enhanced S-cone syndrome","bookWebsiteJournalTitle":"Nippon Ganka Gakkai Zasshi","date":"2009 Oct;113(10):980-90","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/pubmed/19882934","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":3468,"authors":"Audo I, Michaelides M, Robson AG, Hawlina M, Vaclavik V, Sandbach JM, Neveu MM, Hogg CR, Hunt DM, Moore AT, Bird AC, Webster AR, Holder GE","articleTitle":"Phenotypic Variation in Enhanced S-cone Syndrome","bookWebsiteJournalTitle":"Invest Ophthalmol Vis Sci","date":"2008 May;49(5):2082-93","volume":"","pages":"","url":"http://www.iovs.org/content/49/5/2082.long","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11540,"authors":"Bušic M, Bjeloš M, Bosnar D, Ramic S & Bušic I","articleTitle":"Cystoid macular lesions are resistant to topical dorzolamide treatment in enhanced S-cone syndrome child","bookWebsiteJournalTitle":"Doc Ophthalmol","date":"February, 2016","volume":"132(1)","pages":"67-73","url":"https://www.ncbi.nlm.nih.gov/pubmed/?term=26803827","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":30692,"abbreviatedInquiry":"I would appreciate receiving information about the diagnosis, prognosis and treatment of patients with Goldmann Favre vitreoretinal disorder.","caseQuestions":[{"questionId":4496,"questionText":"What is Goldmann-Favre syndrome?","answerText":"<strong>Goldmann-Favre syndrome</strong>, also known as the severe form of enhanced S-cone syndrome, is a inherited eye disease that affects the&nbsp;light-sensitive part of the eye (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002291.htm\" target=\"_blank\">retina</a>). Within the retina are&nbsp;\"red,\" \"blue,\" and \"green\" cones which allow us to&nbsp;see colors properly; and&nbsp;rods which allows us to see in dim light.&nbsp;People with Goldmann-Favre syndrome are born with an overabundance of blue cones, a reduced number of red and green cones, and few, if any, functional rods.[3464] As a result they experience an increased sensitivity to blue light, varying degrees of red and green&nbsp;cone vision, night blindness occurring from early life, vision loss, and retinal degeneration.[3461] Goldmann-Favre syndrome can be caused by mutations in the <em><a href=\"http://ghr.nlm.nih.gov/gene/NR2E3\" target=\"_blank\">NR2E3</a> </em><a href=\"http://ghr.nlm.nih.gov/handbook/basics/gene\" target=\"_blank\">gene </a>and is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> fashion.[3461]Treatment may include <a href=\"http://www.njretina.com/provided-services/treatments-for-retinal-disease/laser-photocoagulation/\" target=\"_blank\">laser photocoagulation</a> and medication, such as <a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a682756.html\" target=\"_blank\">acetazolamide</a>, <a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a697049.html\" target=\"_blank\">dorzolamide</a> and&nbsp;<span><a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a601207.html\" target=\"_blank\">cyclosporin A</a>.[11540][11541]&nbsp;</span>","dateModified":"2016-05-19T00:00:00","references":[{"referenceId":3461,"authors":"","articleTitle":"NR2E3","bookWebsiteJournalTitle":"Genetics Home Reference","date":"January 2016","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/gene/NR2E3","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":3464,"authors":"Sharon D, Sandberg M, Caruso R, Berson EL & Dryja TP","articleTitle":"Shared Mutations in NR2E3 in Enhanced S-cone Syndrome, Goldmann-Favre Syndrome, and Many Cases of Clumped Pigmentary Retinal Degeneration","bookWebsiteJournalTitle":"Arch Ophthalmol","date":"2003 Sept","volume":"121(9)","pages":"1316-23","url":"http://www.ncbi.nlm.nih.gov/pubmed/12963616","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11540,"authors":"Bušic M, Bjeloš M, Bosnar D, Ramic S & Bušic I","articleTitle":"Cystoid macular lesions are resistant to topical dorzolamide treatment in enhanced S-cone syndrome child","bookWebsiteJournalTitle":"Doc Ophthalmol","date":"February, 2016","volume":"132(1)","pages":"67-73","url":"https://www.ncbi.nlm.nih.gov/pubmed/?term=26803827","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11541,"authors":"Salvatore S, Fishman GA & Genead MA","articleTitle":"Treatment of cystic macular lesions in hereditary retinal dystrophies","bookWebsiteJournalTitle":"Surv Ophthalmol","date":"November-December, 2013","volume":"58(6)","pages":"560-84","url":"https://www.ncbi.nlm.nih.gov/pubmed/?term=24160730","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":4497,"questionText":"How is Goldmann-Favre syndrome diagnosed?","answerText":"Goldmann-Favre syndrome may be suspected following <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003881.htm\" target=\"_blank\">ophthalmoscopy</a>&nbsp;examination. Ophthalmoscopy, also known as funduscopy,&nbsp;allows the doctor to&nbsp;look at the&nbsp;back part of the eye (fundus), which includes the <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002291.htm\" target=\"_blank\">retina</a>, optic disc, <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002318.htm\" target=\"_blank\">choroid</a>, and blood vessels. The architecture of the retina in people with Goldmann-Favre syndrome differs remarkably from normal at all disease stages.[3459] Examples of Goldmann-Favre syndrome retinal abnormalities that can be demonstrated by opthalmoscopy include clumps of pigment and atrophic lesions.[3459] <br />\r\n<br />\r\nOther tests that may be used in diagnosing Goldmann-Favre syndrome&nbsp;include <a href=\"http://www.texasheart.org/HIC/Topics/Diag/diag_oct.cfm\" target=\"_blank\">optical coherence tomography</a>,&nbsp;<a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/003388.htm\" target=\"_blank\">electroretinograms</a>, and <a href=\"https://ghr.nlm.nih.gov/primer/testing/genetictesting\" target=\"_blank\">genetic tests</a>. Optical coherence tomography produces&nbsp;specialized photos that show the layers of the retina in cross section. In people with Goldmann-Favre syndrome, optical coherence tomography shows increased retinal thickening.[3459] Electroretinograms measure the activity of the cells in the&nbsp;retina.&nbsp;In Goldmann-Favre syndrome, electroretinograms may demonstrate no or diminished activity in these cells.[3460][11543] Genetic testing to search for disease causing <a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>  in the <em>NR2E3 </em>gene&nbsp;may be used to&nbsp;confirm a suspected diagnosis.[3460]&nbsp;","dateModified":"2011-05-16T15:23:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":3459,"authors":"Jacobson SG, Sumaroka A, Aleman TS, Cideciyan AV, Schwartz SB, Roman AJ, McInnes RR, Sheffield VC, Stone EM, Swaroop A, Wright AF","articleTitle":"Nuclear receptor NR2E3 gene mutations distort human retinal laminar architecture and cause an unusual degeneration","bookWebsiteJournalTitle":"Hum Mol Genet","date":"2004 Sep 1","volume":"","pages":"","url":"http://hmg.oxfordjournals.org/content/13/17/1893.long","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":3460,"authors":"","articleTitle":"Enhanced S-cone syndrome","bookWebsiteJournalTitle":"Online Mendelian Inheritance in Man","date":"2016","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/omim/268100","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11543,"authors":"Sustar M, Perovšek D, Cima I, Stirn-Kranjc B, Hawlina M & Brecelj J","articleTitle":"Electroretinography and optical coherence tomography reveal abnormal post-photoreceptoral activity and altered retinal lamination in patients with enhanced S-cone syndrome","bookWebsiteJournalTitle":"Doc Ophthalmol","date":"June, 2015","volume":"130(3)","pages":"165-77","url":"https://www.ncbi.nlm.nih.gov/pubmed/?term=25663266","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":4498,"questionText":"How might Goldmann Favre syndrome be treated?","answerText":"While treatment options for&nbsp;complications such as,&nbsp;<a href=\"http://dro.hs.columbia.edu/retinoschisis.htm\" target=\"_blank\">retinoschisis</a> and&nbsp;<a href=\"http://www.kellogg.umich.edu/patientcare/conditions/cystoid.macular.edema.html\" target=\"_blank\">cystoid macular edema</a>&nbsp;may be recommended, currently there is not a cure or specific&nbsp;targeted treatment for Goldmann Favre syndrome.[3468][3475]<br />\r\n<br />\r\n<a href=\"http://www.njretina.com/provided-services/treatments-for-retinal-disease/laser-photocoagulation/\" target=\"_blank\">Laser photocoagulation</a>&nbsp;may benefit macular retinoschisis maybe because it results in the debridement of diseased retinal pigment epithelial (RPE) cells and replacement by new cells decreasing the fluid within the macular cysts that could form in the disease.[11541] <br />\r\n<br />\r\nSome improvement of <a href=\"http://www.aoa.org/patients-and-public/eye-and-vision-problems/glossary-of-eye-and-vision-conditions/visual-acuity?sso=y\" target=\"_blank\">visual acuity</a> has been reported after treatments with <a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a601207.html\" target=\"_blank\">cyclosporin A</a> and <a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a682079.html\" target=\"_blank\">bromocriptine</a>.[11542]&nbsp;<a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a682756.html\" target=\"_blank\">Acetazolamide</a>, 125 mg twice daily and topical 2%&nbsp;<a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a697049.html\" target=\"_blank\">dorzolamide</a>&nbsp;have also worked for some patients with macular edema.[11540][11541]&nbsp;","dateModified":"2016-05-19T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":3475,"authors":"Iannaccone A, Fung KH, Eyestone ME, Stone EM","articleTitle":"Treatment of adult-onset acute macular retinoschisis in enhanced s-cone syndrome with oral acetazolamide","bookWebsiteJournalTitle":"Am J Ophthalmol","date":"2009 Feb;147(2):307-312.e2.","url":"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2677970/?tool=pubmed","dateAccessed":"2011-05-16T00:00:00"},{"referenceId":11540,"authors":"Bušic M, Bjeloš M, Bosnar D, Ramic S & Bušic I","articleTitle":"Cystoid macular lesions are resistant to topical dorzolamide treatment in enhanced S-cone syndrome child","bookWebsiteJournalTitle":"Doc Ophthalmol","date":"February, 2016","volume":"132(1)","pages":"67-73","url":"https://www.ncbi.nlm.nih.gov/pubmed/?term=26803827","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11541,"authors":"Salvatore S, Fishman GA & Genead MA","articleTitle":"Treatment of cystic macular lesions in hereditary retinal dystrophies","bookWebsiteJournalTitle":"Surv Ophthalmol","date":"November-December, 2013","volume":"58(6)","pages":"560-84","url":"https://www.ncbi.nlm.nih.gov/pubmed/?term=24160730","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11542,"authors":"","articleTitle":"Goldmann-Favre syndrome","bookWebsiteJournalTitle":"Orphanet","date":"2009","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&data_id=10723","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":4499,"questionText":"What is the typical prognosis for people with Goldmann-Favre syndrome?","answerText":"It is difficult to predict how Goldmann-Favre syndrome may affect a person over time, but tipically, the disease is progressive.&nbsp;Symptoms and symptom severity&nbsp;can vary considerably from person to person.&nbsp;Some people with Goldmann-Favre syndrome experience vision loss and retinal involvement&nbsp;from childhood, while others maintain retinal function into old age.[3468][3467]<br />\r\n<br />\r\nIn general, in childhood Goldmann-Favre syndrome may cause <a href=\"http://www.aapos.org/terms/conditions/9\" target=\"_blank\">accommodative esotropia</a> (eye-crossing) and poor night vision.[3465] <a href=\"http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0002015/\" target=\"_blank\">Farsightedness</a>&nbsp;and night blindness appear to be common features in adults. Other variable signs and symptoms&nbsp;in adults include&nbsp;reduced&nbsp;vision in&nbsp;very bright&nbsp;light,[3466]&nbsp;variable degrees of&nbsp;central vision loss,[3468]&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001015.htm\" target=\"_blank\">astigmatism</a>,&nbsp;&nbsp;<a href=\"http://dro.hs.columbia.edu/retinoschisis.htm\" target=\"_blank\">retinoschisis</a>, and&nbsp;<a href=\"http://www.kellogg.umich.edu/patientcare/conditions/cystoid.macular.edema.html\" target=\"_blank\">cystoid macular edema</a>.[3468]&nbsp;One review found&nbsp;vision (visual acuity) to range from&nbsp;normal to severely reduced&nbsp;among people with retinas affected by&nbsp;<em>NR2E3 </em>mutations. The presence of&nbsp;<a href=\"http://dro.hs.columbia.edu/retinoschisis.htm\" target=\"_blank\">retinoschisis</a>, may be associated with&nbsp;poorer vision.[3468] Some studies have shown improvement of the vision with treatment.[11540]<br />\r\n<br />\r\nWhile <em>NR2E3 </em>mutations are not identified in all people with Goldmann-Favre syndrome, many cases are caused by mutations in this gene. Symptom and symptom severity is likely influenced by&nbsp;which <em>NR2E3&nbsp;</em>mutations are present, as well as&nbsp;other poorly understood genetic and environmental&nbsp;factors.&nbsp;","dateModified":"2016-05-19T00:00:00","resourceClassificationName":"Prognosis","references":[{"referenceId":3465,"authors":"Khan AO, Aldahmesh M & Meyer B","articleTitle":"The enhanced S-cone syndrome in children","bookWebsiteJournalTitle":"Br J Ophthalmol","date":"March, 2007","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1857689/?tool=pubmed","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":3466,"authors":"Pachydaki SI, Klaver CC, Barbazetto IA, Roy MS, Gouras P, Allikmets R, Yannuzzi LA","articleTitle":"Phenotypic Features of Patients With NR2E3 Mutations","bookWebsiteJournalTitle":"Arch Ophthalmol","date":"2009 Jan;127(1):71-5","volume":"","pages":"","url":"http://archopht.ama-assn.org/cgi/content/full/127/1/71","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":3467,"authors":"Sato T, Kuniyoshi K, Nakao A, Shimomura Y, Tomemori R","articleTitle":"Long-term observation of two cases of enhanced S-cone syndrome","bookWebsiteJournalTitle":"Nippon Ganka Gakkai Zasshi","date":"2009 Oct;113(10):980-90","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/pubmed/19882934","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":3468,"authors":"Audo I, Michaelides M, Robson AG, Hawlina M, Vaclavik V, Sandbach JM, Neveu MM, Hogg CR, Hunt DM, Moore AT, Bird AC, Webster AR, Holder GE","articleTitle":"Phenotypic Variation in Enhanced S-cone Syndrome","bookWebsiteJournalTitle":"Invest Ophthalmol Vis Sci","date":"2008 May;49(5):2082-93","volume":"","pages":"","url":"http://www.iovs.org/content/49/5/2082.long","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11540,"authors":"Bušic M, Bjeloš M, Bosnar D, Ramic S & Bušic I","articleTitle":"Cystoid macular lesions are resistant to topical dorzolamide treatment in enhanced S-cone syndrome child","bookWebsiteJournalTitle":"Doc Ophthalmol","date":"February, 2016","volume":"132(1)","pages":"67-73","url":"https://www.ncbi.nlm.nih.gov/pubmed/?term=26803827","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2567,"questionText":"How can I find a genetics professional in my area?","answerText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by  the <a href=\"https://www.acmg.net/ACMG/Find_Genetic_Services/ACMG/ISGweb/FindaGeneticService.aspx?hkey=720856ab-a827-42fb-a788-b618b15079f9\" target=\"_blank\">American College of Medical Genetics</a>&nbsp;and the&nbsp;<a href=\"https://www.findageneticcounselor.com/\" target=\"_blank\">National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also <a href=\"http://ghr.nlm.nih.gov/handbook/consult?show=all\" target=\"_blank\">learn more about genetic consultations</a> from Genetics Home Reference.","dateModified":"2017-12-06T00:00:00","references":[]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":5624,"phenoTypeName":"Cataract","percentRanges":"-"},{"phenoTypeId":8259,"phenoTypeName":"Edema","percentRanges":"-"},{"phenoTypeId":1680,"phenoTypeName":"Hemeralopia","percentRanges":"-"},{"phenoTypeId":6825,"phenoTypeName":"Macular edema","percentRanges":"-"},{"phenoTypeId":10138,"phenoTypeName":"Nyctalopia","percentRanges":"-"},{"phenoTypeId":9805,"phenoTypeName":"Pigmentary retinopathy","percentRanges":"-"},{"phenoTypeId":6682,"phenoTypeName":"Retinoschisis","percentRanges":"-"},{"phenoTypeId":5656,"phenoTypeName":"Undetectable electroretinogram","percentRanges":"-"},{"phenoTypeId":8457,"phenoTypeName":"Vitreoretinopathy","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Goldmann-Favre_syndrome"}